Literature DB >> 12566547

Evaluation and treatment of dyspepsia.

M P Jones1.   

Abstract

Dyspepsia is a common symptom. Dyspeptic symptoms may be caused by a variety of conditions such as peptic ulcer disease, gastro-oesophageal reflux, and malignancy. Most often, however, no cause is identified and dyspepsia is deemed to be functional. While symptom severity does influence frequency of consultation, dyspeptic consulters also differ from non-consulters with respect to symptom perception and anxiety. This highlights the importance of understanding the patient's agenda early in the course of evaluation. Patients over the age of 55 years or with alarm symptoms should be referred for prompt endoscopy. In the absence of other clinically apparent aetiologies, uninvestigated dyspeptics can be either tested and treated for Helicobacter pylori or empirically treated with proton pump inhibitors. Uninvestigated dyspeptics failing empiric therapy should be referred for evaluation that includes endoscopy. Further therapy with prokinetics, tricyclic antidepressants, fundal relaxants, antidepressants, or psychotherapy is guided by predominant symptoms and assessment of possible psychiatric factors.

Entities:  

Mesh:

Year:  2003        PMID: 12566547      PMCID: PMC1742581          DOI: 10.1136/pmj.79.927.25

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  38 in total

Review 1.  AGA technical review: evaluation of dyspepsia. American Gastroenterological Association.

Authors:  N J Talley; M D Silverstein; L Agréus; O Nyrén; A Sonnenberg; G Holtmann
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

2.  Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.

Authors:  S J Veldhuyzen van Zanten; C Cleary; N J Talley; T C Peterson; O Nyrén; L A Bradley; M Verlinden; G N Tytgat
Journal:  Am J Gastroenterol       Date:  1996-04       Impact factor: 10.864

3.  The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].

Authors:  I Mason; L J Millar; R R Sheikh; W M Evans; P L Todd; M L Turbitt; M D Taylor
Journal:  Aliment Pharmacol Ther       Date:  1998-03       Impact factor: 8.171

4.  Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice.

Authors:  R H Jones; G Baxter
Journal:  Aliment Pharmacol Ther       Date:  1997-06       Impact factor: 8.171

5.  Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models.

Authors:  P Bytzer; J M Hansen; O B Schaffalitzky de Muckadell; A Malchow-Møller
Journal:  Scand J Gastroenterol       Date:  1997-02       Impact factor: 2.423

6.  New noninvasive tests for Helicobacter pylori gastritis. Comparison with tissue-based gold standard.

Authors:  D O Faigel; M Childs; E E Furth; A Alavi; D C Metz
Journal:  Dig Dis Sci       Date:  1996-04       Impact factor: 3.199

7.  Gastric myoelectrical activity, gastric emptying and correlations with dyspepsia symptoms in patients with gastroesophageal reflux.

Authors:  I Soykan; Z Lin; S Jones; J Chen; R W McCallum
Journal:  J Investig Med       Date:  1997-10       Impact factor: 2.895

8.  Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.

Authors:  N J Talley; N Vakil; E D Ballard; M B Fennerty
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

9.  Impact of functional dyspepsia on quality of life.

Authors:  N J Talley; A L Weaver; A R Zinsmeister
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

10.  Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

Authors:  V Stanghellini; C Tosetti; A Paternico; G Barbara; A M Morselli-Labate; N Monetti; M Marengo; R Corinaldesi
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  5 in total

Review 1.  Central serotonergic and noradrenergic receptors in functional dyspepsia.

Authors:  S O'Mahony; T G Dinan; P W Keeling; A S B Chua
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 2.  Functional dyspepsia: are psychosocial factors of relevance?

Authors:  Sandra Barry; Timothy G Dinan
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

3.  A Study of Psychological Factors Associated with Functional Gastrointestinal Disorders and Use of Health Care.

Authors:  Sang-Yeol Lee; Han-Seung Ryu; Suck-Chei Choi; Seung-Ho Jang
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-11-30       Impact factor: 2.582

4.  Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial.

Authors:  Bhupesh Dewan; Nisha Philipose
Journal:  Gastroenterol Res Pract       Date:  2011-05-05       Impact factor: 2.260

5.  Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia.

Authors:  Somnath Maity; Supriyo Choudhury; Avijit Hazra; Amal Kanti Das
Journal:  Indian J Pharmacol       Date:  2014 Sep-Oct       Impact factor: 1.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.